nivolumab,visugromab
bms,catal ym
['gdfather']
see #jitc section editor of take the stage at #asco23 to share initial results from the phase 2a gdfather-trial at 9:45am ct. in the meantime, read about gdf15 from zhaowei wang et al in #jitc: 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)